Jefferies Upgrades The Medicines Company (MDCO) to Buy, Attractive Reward/Risk
Tweet Send to a Friend
Jefferies upgraded The Medicines Company (NASDAQ: MDCO) from Hold to Buy with a price target of $34.00 (from $24.00).
This article: 150 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 150 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
